IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.
about
Integrated network analysis of transcriptomic and proteomic data in psoriasisPhototherapy in psoriasis: a review of mechanisms of actionJakpot! New small molecules in autoimmune and inflammatory diseasesCytokines in psoriasisEmerging drugs for moderate-to-severe psoriasis.Interleukin 10-induced thrombocytopenia in normal healthy adult volunteers: evidence for decreased platelet production.Interleukin-10 suppression of myeloid cell activation--a continuing puzzle.Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumabEnriched protein screening of human bone marrow mesenchymal stromal cell secretions reveals MFAP5 and PENK as novel IL-10 modulators.The immunologic effects of estrogen on psoriasis: A comprehensive review.Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?Interleukin-10: an anti-inflammatory cytokine with therapeutic potential.Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions.Interleukin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins.Activation of the IL-10 gene promoter following photodynamic therapy of murine keratinocytesThe treatment of psoriasis with IL-10: rationale and review of the first clinical trials.Inhibitory effects of interleukin-10 plasmid DNA on the development of atopic dermatitis-like skin lesions in NC/Nga mice.New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppressionRole of interleukin 10 transcriptional regulation in inflammation and autoimmune diseaseRecent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators.Interleukin-10 repletion suppresses pro-inflammatory cytokines and decreases liver pathology without altering viral replication in murine cytomegalovirus (MCMV)-infected IL-10 knockout mice.Cytokine therapy in dermatology.Cytokines in multiple sclerosis: methodological aspects and pathogenic implications.Chafuroside B, an Oolong tea polyphenol, ameliorates UVB-induced DNA damage and generation of photo-immunosuppression related mediators in human keratinocytes.Antioxidant and anti-inflammatory activity of Ocimum labiatum extract and isolated labdane diterpenoid.Th2 Cytokines and Atopic Dermatitis.A randomised placebo controlled trial of delipidated, deglycolipidated Mycobacterium vaccae as immunotherapy for psoriatic arthritis.Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation.Emerging drugs in psoriasis.Cutting edge: IL-10-mediated tristetraprolin induction is part of a feedback loop that controls macrophage STAT3 activation and cytokine production.Animal models of psoriasis.Exopolysaccharides Isolated from Milk Fermented with Lactic Acid Bacteria Prevent Ultraviolet-Induced Skin Damage in Hairless MiceThe role of T cells in cutaneous autoimmune disease.Immunotherapy for the prevention and treatment of type 1 diabetes.IL-10+ Innate-like B Cells Are Part of the Skin Immune System and Require α4β1 Integrin To Migrate between the Peritoneum and Inflamed SkinCurrent and potential immune therapies and vaccines in the management of psoriasis.Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation.CD19+ B cell subsets in the peripheral blood and skin lesions of psoriasis patients and their correlations with disease severity
P2860
Q24610642-7DF3BD4A-ABDD-4181-8BED-5A2BE6876EF6Q24633097-BD8FD18F-1F9B-431F-9B17-AFC1F4AD3274Q27001957-135064C3-D370-4F3A-8D66-10C9D6943240Q28255491-D0181E8A-3190-4C62-9158-10F91A0C247FQ30984470-C8F056FD-1B2F-44ED-A3B0-DF780445F1AAQ33335197-AD6352E5-AE97-456D-9092-D74B871E16A1Q33340529-75917C63-CE22-491F-9DEB-CD5482384F86Q33573621-D4831768-CFB8-4791-ADD4-A04EC0E6CA54Q33595061-2324B010-87FE-4A4C-A19A-AF4D4CABB22DQ33640627-EC6D5089-E801-4D78-A382-ECAF6CBD33DFQ33655250-70AC828B-34E0-4F5B-A158-0899B7DAF7CFQ33723684-6931C07E-CCAB-4B85-9F62-119B47857E51Q33902313-39B62B06-7684-4FA7-9845-D7933B891FF2Q34005163-BDFA9633-749C-4F2E-960B-DE6C2CB00154Q34056351-23756E82-BC7E-40BD-9E18-5DF706C685CAQ34074672-26E152AB-F35A-48AF-98D4-CEEC6CC7D374Q34075763-87A6C424-30E1-406D-857A-45076D4C99AAQ34175958-62498A50-FF4F-401B-890A-F994DF3F81FBQ34262223-D441FFFC-3793-4B98-B024-FA6F365E80BFQ34327203-581374BF-FCA7-42F2-9F86-0D4329535A33Q34435158-0775489C-9DC5-414D-8D50-BB76DFB98EBAQ34565123-41C1D26F-CE3C-4C6B-8CF7-1541A8692B20Q34626999-C8CE236B-2ADA-47FA-8273-37C38835F0C2Q34924266-A8CC7AD0-9C29-436F-BBA5-60E8C9C75C21Q35015127-932FFF50-7E27-4DCF-9BE9-2B771EAD8E9CQ35105010-308DF501-044B-438D-9B77-2B6B40183D51Q35294155-DB82DA71-B2E2-49F6-95CA-392B6BC3A8ACQ35554193-F16C5EDB-ABFE-43C7-B586-9710C5FF6C98Q35680472-F92E8F90-FEC2-46D7-8AE2-64EE8D913029Q35716177-3CAB6F44-7C53-4C15-B9B0-14014AA86974Q36179686-FF005FD7-3592-4A31-8BA2-F4986CFEC56BQ36179832-8F48B60F-F606-4E90-AE4C-4838CEA1A7B0Q36181290-7FA5E625-4302-40E7-93B9-3DDC61982C20Q36252419-7559A3DD-7774-4F27-B4AA-C77F58FA8D3EQ36277428-3785E37D-42EE-4889-805D-89E6FB7DC184Q36327355-D0F6CA54-B952-4BD8-989F-069EE13B11FBQ36655727-50997C14-21FA-4961-A1E5-9B38AE39539AQ36977772-35587238-0A65-4F6C-8BF0-BBD5745D8A9DQ37176336-3B8D25A2-1097-42E5-96FE-D6AAF073C6B5Q37191197-311A1E30-CF13-441D-A51B-BFCB95518280
P2860
IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IL-10 is a key cytokine in pso ...... y: a new therapeutic approach.
@en
IL-10 is a key cytokine in pso ...... y: a new therapeutic approach.
@nl
type
label
IL-10 is a key cytokine in pso ...... y: a new therapeutic approach.
@en
IL-10 is a key cytokine in pso ...... y: a new therapeutic approach.
@nl
prefLabel
IL-10 is a key cytokine in pso ...... y: a new therapeutic approach.
@en
IL-10 is a key cytokine in pso ...... y: a new therapeutic approach.
@nl
P2093
P2860
P356
P1476
IL-10 is a key cytokine in pso ...... y: a new therapeutic approach.
@en
P2093
Asadullah K
Jasulaitis D
Stephanek K
P2860
P304
P356
10.1172/JCI1476
P407
P577
1998-02-01T00:00:00Z